ArticleFrontiers in immunology2023

Low-dose post-transplant cyclophosphamide with G-CSF/ATG based haploidentical protocol provides favorable outcomes for SAA patients.

Xiaodi Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.